FundedIQ
Biotechnology

Kepler: Funding, Investors & Team (Sep 2026)

Kepler is an open science stage for finding, peer inspecting, and distributing logical papers. The organization was established in 2021 and is settled in Brooklyn, New York, United States.

www.kepler.co LinkedIn Brooklyn, United States 1-10 employees
Total raised
$7.6M
Rounds
1
Latest
Seed
Jul 2022

Kepler has raised $7.6M across 1 funding round on record, the most recent a Seed of $7.6M announced in Jul 2022.

That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Kepler Company Profile and Key Stats

Total funding raised
$7.6M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$7.6M in Jul 2022
Employees
1-10
reported band
Headquarters
Brooklyn, United States

Latest funding round on record: Jul 2022.

Kepler Funding Rounds

Date
Round
Amount
Seed
$7.6M

Kepler Founders and Leadership Team

Name
Role
Contact
Kenny Teng
Founder
Locked

Contact details for the Kepler team: 1 of 1 has an email address on file.

Start 14-day free trial →

Kepler Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M
16,664
$3.1M

Kepler's latest round of $7.6M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Kepler in Biotechnology and Brooklyn

Companies Similar to Kepler

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Kepler Funding FAQs

What does Kepler do?

Kepler is an open science stage for finding, peer inspecting, and distributing logical papers. The organization was established in 2021 and is settled in Brooklyn, New York, United States.

How much funding has Kepler raised?

Kepler has raised $7.6M across 1 round on record. The most recent is a Seed of $7.6M announced in Jul 2022.

When did Kepler last raise funding?

Kepler's most recent funding round on record is a Seed of $7.6M, announced in Jul 2022.

Who founded Kepler?

FundedIQ lists Kenny Teng (Founder) at Kepler.

Where is Kepler headquartered?

Kepler is based in Brooklyn, New York, United States.

How many employees does Kepler have?

Kepler is in the 1-10 employee band.

How does Kepler's funding compare to other Biotechnology startups?

Kepler's latest round of $7.6M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's Kepler Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kepler is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.